Development of PEDF Protein: An Antiangiogenic Agent

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$775,784.00
Award Year:
2004
Program:
SBIR
Phase:
Phase II
Contract:
2R44EY014769-02
Agency Tracking Number:
EY014769
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
GENVEC, INC.
GENVEC, INC., 65 W WATKINS MILL RD, GAITHERSBURG, MD, 20878
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
LISA Wei
(240) 632-5539
LWEI@GENVEC.COM
Business Contact:
C KING
(240) 632-5537
RKING@GENVEC.COM
Research Institution:
n/a
Abstract
The leading major causes of blindness in the U.S. are exudative age-related macular degeneration (AMD) and proliferative diabetic retinopathy (DR). Both are due to aberrant neovascularization in the eye. PEDF (Pigment Epithelium-Derived Factor) is a poten

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government